The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

Publisher Name :
Date: 01-Jun-2015
No. of pages: 62
Inquire Before Buying

Purpose of Report:  The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportunities within the stem cell biobanking market.

This global strategic report is produced for:


  • Executives of Industrial-Scale Biobanks

  • Management of Stem Cell Product Companies

  • Management of Stem Cell Therapy Companies

  • Biobanking Industry Investors


It is designed to increase your efficiency and effectiveness in:

  • Effectively pricing stem cell biobanking services

  • Increasing revenue from stem cell biobanking services

  • Identifying new or adjunct stem cell biobanking services to offer

  • Identifying current market leaders within the stem cell biobanking market

  • Characterizing the competitive environment for the stem cell biobanking market

  • Identifying threats and opportunities within the stem cell biobanking market

  • Acquiring greater market within the stem cell biobanking market

  • Making intelligent investment decisions within the stem cell biobanking market


Overview

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types.  Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first culturing of embryonic stem cells from non-human primates occurred. Induced pluripotent stem cells were not produced until 2006.  As a result of these discoveries, stem cells can now be derived at various points during the life cycles.

The following are stages during which stem cells can be derived:


  • Embryonic stem cells, derived from blastocysts

  • Fetal stem cells, obtained from fetuses

  • Post-natal stem cells derived from newborn tissues, including cord blood stem cells from umbilical tissue

  • Adult stem cells found in adult tissues, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells

  • Induced pluripotent stem cells, reprogrammed from adult cells

  • Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body

  • And more


Forces Driving the Stem Cell Biobanking Market

Stem cell research and experimentation is largely driven by the unique ability of stem cells to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

Therefore, the possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Huntington’s disease, Parkinson’s disease, and spinal cord injuries are examples of conditions for which clinical applications involving stem cells could offer benefits in halting or even reversing adverse effects.

However, to have stem cells easily accessible for research purposes and clinical applications requires them to be preserved in stable, temperature controlled conditions.  For this reason, a substantial market has evolved for the biobanking of tissues containing stem cell populations and the storage of stem cells themselves.

Stem Cell Biobanking Market

Stem cell biobanking is the cryogenic storage of stem cells, or biological samples containing stem cells, for later use. The market for these services is known as the “Stem Cell Biobanking Market.” Because stem cell biobanking often involves the long-term storage of stem cell samples, the market is sometimes is also known as the “Stem Cell Storage Market.” For purposes of this analysis, these two terms are considered to be synonymous. A definition of this market is provided below.

Stem Cell Biobanking Market:  The stem cell biobanking market is defined as the total annual revenue derived from the storage of:


  • Stem cell lines and their derivatives

  • All biological samples that were collected specifically because they contain stem cell populations (e.g. cord blood, adipose tissue, and more)


This report aims to understand and characterize the competitive environment for the stem cell biobanking market. As such, the research is focused on identifying leading participants in the stem cell storage market, distinguishing their business model, and exploring their relative market share.

Currently, the four leading providers of biobanking services are: Fisher Bioservices, Biostorage Technologies, EPL Archives, and Precision Bioservices. All four companies store millions of biological samples (15 million by Precision Bioservices, up to 170 million by Fisher Bioservices) and provide a diverse set of biobanking services. All but Precision Biosciences are multi-national companies with both U.S. and European operations.  Because each company has  large market share within the stem cell biobanking market, they are explored in detail within this report.

However, there are also companies specializing exclusively in stem cell storage.  In one landmark event, Cellular Dynamics International (CDI) and the Coriell Institute for Medical Research announced receiving multi-million dollar grants from the California Institute for Regenerative Medicine (CIRM) for the creation of induced pluripotent stem cell (iPSC) lines from 3,000 healthy and diseased donors.  CIRM awarded CDI $16 million to create three iPSC lines for each of 3,000 healthy and diseased donors and awarded the Coriell Institute $10 million to set up and biobank the iPSC lines. The result will be thecreation of the world’s largest human iPSC bank, an incredible feat.

This iPSC biobank is one example of the expanding market for stem cell biobanking services. Because the goal of stem cell biobanking is to create a repository of stem cell specimens – including source tissue from which stem cells can be derived, differentiated cell types produced, and disease-specific cell lines created – large-scale stem cell biobanks provide researchers with the opportunity to investigate a diverse range of conditions using stem cells derived from both healthy and diseased donors. Importantly, biobanks can greatly expand the capacity for global research and collaboration.

Key report findings include:


  • Current Size of the Stem Cell Biobanking Market

  • Trailing 5-Year Market Size Data (2011-2015)

  • 5-year Market Size Projections (2016-2020)

  • Market Segmentation

  • Market Share by Segment

  • Key Industry Leaders

  • Detailed Competitive Environment Analysis

  • Analysis of Stem Cell Storage Applications (End-Uses)

  • Number of Stem Cell Samples Banked, by Industry Leader

  • Identification of  Opportunities within the Stem Cell Biobanking Market

  • And Much More


Competing within the stem cell biobanking market can involve complicated and confusing decisions, but it doesn’t need to. Claim this global strategic report to quickly understand current and future trends within the stem cell biobanking marketplace, identify opportunities by market segment, and derive more revenue from your stem cell biobanking products and services.

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

Table of Contents

1. Introduction
1.1. Definitions
1.2. Stem Cell Biobanking Market
1.3. Stem Cell Biobanking Market Segments
[Table] Stem Cell Biobanking Market Segments
1.4. Stem Cell Biobanking Market Leaders

2. Scope

3. Goals Of Report

4. Methodology
4.1. Input Sources
4.2. Research & Analysis Methodologies

5. Applications For Stored Stem Cells (End-Uses)
5.1. Biobanking
5.1.1. Cord Blood Banking
[Image] Comparison of Umbilical Cord Blood vs. Umbilical Cord Tissue
5.1.2. Bone Marrow & Peripheral Blood Specimens
5.1.3. Dental Stem Cell Storage
[Table] Companies Offering Dental Stem Cell Storage
5.1.4. Adipose-Derived Stem Cell Storage
[Image] Companies Offering Adipose-Derived Stem Cell Storage
5.1.5. Amniotic Fluid Storage
5.1.6. Storage of Assisted Reproduction Specimens
5.2. Medical Applications
5.2.1. Cellular Therapy
5.2.2. Regenerative Medicine
5.2.3. Tissue Engineering
5.2.4. Personalized Therapeutics
5.3. Scientific Research
5.3.1. Basic Research
5.3.2. Applied Research

6. Market Size Determinations For The Stem Cell Biobanking Market
6.1. Annual Revenue from Stem Cell Storage, by Market Segment
[Table] Annual Revenue From Stem Cell Storage, By Market Segment
[Graph] Annual Revenue from Stem Cell Storage, by Market Segment
6.2. Market Size Determinations for the Stem Cell Storage Market
6.2.1. Global Market Size
6.2.2. North American Market Size

7. Basic Variables For The Stem Cell Biobanking Market
7.1. Approximate Length of Time Stem Cell Samples are Stored
[Table] Storage Durations, by Market Segment
7.2. Temperature Requirements
[Table] Temperature Requirements for Stem Cell Biobanking
7.3. Logistical Variables

8. Industry LEAdERS
8.1. Key Types of Stem Cells Stored by Industry Leader
[GrAPH] Stem Cell Biobanking Market – Market Share by Industry Leader
8.1.1. Fisher BioServices
8.1.2. BioStorage Technologies
[Table] Range of Cryogenic Services Offered by BioStorage Technologies
8.1.3. EPL Archives
[Table] Range of Cryogenic Services Offered by EPL Archives
8.1.4. Precision Bioservices
[Table] Range of Cryogenic Services Offered by Precision Bioservices
8.2. Analysis of Fundamental Services Provided by Industry Leaders (Storage, Logistics, Scientific Services, Other)
8.2.1. Fisher BioServices
8.2.2. BioStorage Technologies
8.2.3. EPL Archives
8.2.4. Precision Bioservices

9. Breakdown Of Market Share, By Customer
[Graph] Stem Cell Biobanking Market – Breakdown of Market Share by End-User

10. Market Characterization
10.1. “Pure Play” Storage Companies and Percentage of Total Market as Storage
[Table] Market Segments for Stem Cell Storage, by End-User
10.2. Percentage of Stem Cell Biobanking Market that is Storage (versus Related Services)
[Table] Breakdown of Stem Cell Biobanking Market: Storage vs. Related Services
[Graph] Breakdown of Stem Cell Biobanking Market: Storage vs. Related Services

11. Market Size Growth Rate Determinations – Trailing 5-Year Data & 5-Year Projections Through 2020
11.1. Global Analysis
[Table] Trailing 5-Year Market Size Determinations for Global Stem Cell Biobanking Market (2011-2015)
[Graph] Trailing 5-Year Market Size Determinations for Global Stem Cell Biobanking Market (2011-2015)
[Table] 5-Year Projections for Global Stem Cell Biobanking Market (2016-2020)
[GrAPH] 5-Year Projections for Global Stem Cell Biobanking Market (2016-2020)
11.2. North American Analysis
[Table] Trailing 5-Year Market Size Determinations for North American Stem Cell Biobanking Market (2011-2015)
[Graph] Trailing 5-Year Market Size Determinations for North American Stem Cell Biobanking Market (2011-2015)
[Table] 5-Year Projections for N. American Stem Cell Biobanking Market (2016-2020)
[Graph] 5-Year Projections for N. American Stem Cell Biobanking Market (2016-2020)

Appendices
Appendix A – Complete List of Stem Cell Types
Appendix B – Global List of Biobanks and Biorepositories, by Geographical Region

European Biobanks
North American Biobanks
United States Biobanks
Asian Biobanks
Australian Biobanks
Middle Eastern Biobanks

  • Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021
    Published: 28-Feb-2017        Price: US 5650 Onwards        Pages: 120
    The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for development of stem cell therapies, identification of new stem cell lines, and development......
  • Global Stem Cell Therapy Market Research Report 2017
    Published: 16-Feb-2017        Price: US 2900 Onwards        Pages: 111
    Notes: Production, means the output of Stem Cell Therapy Revenue, means the sales value of Stem Cell Therapy This report studies Stem Cell Therapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Cellular Dynamics International - Osiris Therapeutics - Vcanbio......
  • Global Stem Cell Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 11-Feb-2017        Price: US 3480 Onwards        Pages: 105
    Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).Scope of the Report:This report focuses on the Stem Cell in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categori......
  • Europe Stem Cell Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 11-Feb-2017        Price: US 4480 Onwards        Pages: 105
    Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).Scope of the Report:This report focuses on the Stem Cell in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, ......
  • Global Stem Cell Therapy Market 2017-2021
    Published: 25-Jan-2017        Price: US 3500 Onwards        Pages: 70
    Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions. The an......
  • China Stem Cell UCB Market Research Report 2017
    Published: 16-Jan-2017        Price: US 3200 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Stem Cell UCB Revenue, means the sales value of Stem Cell UCB This report studies Stem Cell UCB in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Caladrius Biosciences? - Celgene? - Mesoblast? - Pluristem Therapeutics - Athersys - CHA Bio & Diostech? - Cytori Therapeutics......
  • Europe Stem Cell UCB Market Report 2017
    Published: 13-Jan-2017        Price: US 3900 Onwards        Pages: 112
    Notes: Sales, means the sales volume of Stem Cell UCB Revenue, means the sales value of Stem Cell UCB This report studies sales (consumption) of Stem Cell UCB in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Caladrius Biosciences? - Celgene? - Mesoblast? - Pluristem Ther......
  • Global Stem Cell UCB Market Professional Survey Report 2017
    Published: 12-Jan-2017        Price: US 3500 Onwards        Pages: 121
    Notes: Production, means the output of Stem Cell UCB Revenue, means the sales value of Stem Cell UCB This report studies Stem Cell UCB in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share fo......
  • Global Stem Cell UCB Market Research Report 2016
    Published: 23-Dec-2016        Price: US 2900 Onwards        Pages: 112
    Notes: Production, means the output of Stem Cell UCB Revenue, means the sales value of Stem Cell UCB This report studies Stem Cell UCB in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Caladrius Biosciences - Celgene - Mesoblast - Pluristem Therapeutics - Ather......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs